Samantha McLemore’s Bausch Health BHC Stock Holding History

Samantha McLemore’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-187,600	Closed	-$1.29M	–	44
2022 Q3	$1.29M	Sell	187,600 -217,900	-54%	-$1.51M	0.65%	37
2022 Q2	$3.39M	Buy	405,500 +134,200	+49%	+$1.88M	1.5%	30
2022 Q1	$6.2M	Sell	271,300 -19,000	-7%	-$464K	2.1%	22
2021 Q4	$8.02M	Buy	+290,300	New	+$7.77M	2.31%	16

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.26B AUM 15.11% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Samantha McLemore's BHC Position: Q4 2022 in Review

Samantha McLemore sold out of Bausch Health (BHC) in Q4 2022, closing a stake of 187,600 shares — an estimated $1.29M sold.

Samantha McLemore first reported a position in BHC in Q4 2021 and held it in 4 quarters. The position peaked at $8.02M in Q4 2021. 262 funds tracked by Wall St. Rank hold BHC as of Q4 2022.

Samantha McLemore reported no remaining Bausch Health position as of Q4 2022 after selling out during the quarter.
Samantha McLemore sold 187,600 Bausch Health shares in Q4 2022, an estimated $1.29M.
Samantha McLemore first reported a position in Bausch Health in Q4 2021 and held it in 4 quarters.
Samantha McLemore's Bausch Health position peaked at $8.02M in Q4 2021.
262 funds tracked by Wall St. Rank held Bausch Health as of Q4 2022.

Based on Patient Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.